Elanco Animal Health
ELAN
419 hedge funds and large institutions have $5.76B invested in Elanco Animal Health in 2022 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 160 increasing their positions, 143 reducing their positions, and 81 closing their positions.
299% more call options, than puts
Call options by funds: $110M | Put options by funds: $27.5M
12% more repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 143
1.53% less ownership
Funds ownership: 99.27% → 97.74% (-1.5%)
4% less funds holding
Funds holding: 438 → 419 (-19)
21% less first-time investments, than exits
New positions opened: 64 | Existing positions closed: 81
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
38% less capital invested
Capital invested by funds: $9.24B → $5.76B (-$3.48B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$179M |
| 2 |
Amundi
Paris,
France
|
+$116M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$94.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$85.2M |
| 5 |
Millennium Management
New York
|
+$72.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aristotle Capital Management
Los Angeles,
California
|
-$411M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$179M |
| 3 |
Goldman Sachs
New York
|
-$144M |
| 4 |
SV
Starboard Value
New York
|
-$113M |
| 5 |
SC
Sculptor Capital
New York
|
-$65.1M |
ELAN Hedge Fund Activity: Q3 2022 in Review
419 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2022, worth a combined $5.76B — down 38% from $9.24B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of ELAN and 64 opened new positions — a net loss of 17 holders — while 143 trimmed existing stakes and 160 added.
The largest buyer was Citadel Advisors, adding an estimated $179M. The largest seller was Aristotle Capital Management, cutting an estimated $411M.
- 419 institutional investors held Elanco Animal Health (ELAN) as of Q3 2022, down from 438 in Q2 2022.
- Funds reported $5.76B of Elanco Animal Health stock for Q3 2022, down 38% quarter-over-quarter.
- 64 funds opened new Elanco Animal Health positions in Q3 2022 and 81 closed out, a net change of -17 holders.
- The largest Elanco Animal Health buyer in Q3 2022 was Citadel Advisors, an estimated $179M added.
- The largest Elanco Animal Health seller in Q3 2022 was Aristotle Capital Management, an estimated $411M sold.
Based on aggregated 13F filings for Q3 2022.